| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |